Detailed answers about MEDTURK HEALTH SOLUTIONS AND RESEARCH LIMITED, including incorporation, status, business activity, and accounts information.
When was MEDTURK HEALTH SOLUTIONS AND RESEARCH LIMITED founded?
MEDTURK HEALTH SOLUTIONS AND RESEARCH LIMITED was officially incorporated on 7 July 2025 and is registered under company number 16566151. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is MEDTURK HEALTH SOLUTIONS AND RESEARCH LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of MEDTURK HEALTH SOLUTIONS AND RESEARCH LIMITED?
MEDTURK HEALTH SOLUTIONS AND RESEARCH LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does MEDTURK HEALTH SOLUTIONS AND RESEARCH LIMITED do?
MEDTURK HEALTH SOLUTIONS AND RESEARCH LIMITED operates in the following sector: 86900 - Other human health activities. This provides insight into the company's primary business activity and industry focus.
What is MEDTURK HEALTH SOLUTIONS AND RESEARCH LIMITED's registered address?
The registered office address of MEDTURK HEALTH SOLUTIONS AND RESEARCH LIMITED is 77 EAST ROAD, STUDIO SHOREDITCH BSL, LONDON, GREATER LONDON, ENGLAND, N1 6AH. This is the official address filed with Companies House for legal and statutory correspondence.
Is MEDTURK HEALTH SOLUTIONS AND RESEARCH LIMITED financially stable?
Financial accounts for MEDTURK HEALTH SOLUTIONS AND RESEARCH LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.